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Bioceramics, such as silica-based glasses, are widely us d in bone and teeth restoration. Nowadays, 
the association between nanotechnology and pharmacology is one of the most promising research 
fields in cancer therapy. The advanced processing methods and new chemical strategies allow the 
incorporation of drugs within them or on their functionalized surfaces. Bioceramics can act as local 
drug delivery systems to treat bone and teeth deseas . 
The present paper reports data related to the developm nt of a pH-stimuli responsive bioactive 
glass. The glass conjugation with 5-aminofluorescein (5-AF), through a pH-sensitive organic 
spacer, allows to produce a pH-responsive bioactive biomaterial: when it is exposed to specific pH 
changes, it can favour the release of 5-AF directly at the target site. 
5-aminofluorescein has been chosen as a simple, low c st, non toxic models to simulate 
doxorubicin an anticancer drug. As doxorubicin, 5-AF contains an amino group in its structure in 
order to form an amide bond with the carboxylic functionalities of the glass. Raman spectroscopy 
and thermal analysis confirm the glass conjugation of 5-AF by means of an amide bond; the amount 
of 5-AF loaded was very high (≈ 65 and 44 wt%). The release tests at two different pH (4.2 and 7.4) 
show that the amount of released 5-AF is higher at acid pH with respect to physiological one. This 
preliminary datum evidenced that a pH-sensitive drug delivery system has been developed. The low 
amount of 5-AF released (2% <1 wt%. of the total 5-AF) is due to the very low solubility of 5-AF 
in aqueous medium. This disadvantage, may be overcome in a dynamic environment (physiological 
conditions), where it is possible to obtain a drug elease system ensuring an effective therapeutic 
dose for long times and, at the same time, avoiding the drug toxicity. 
 
 
Keywords: Bioceramics, Controlled drug delivery, pH-Responsive bioactive glass; Covalent 
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Introduction  
Bioceramics, such as calcium phosphates, cements and silica-based glasses, are widely used as 
components of implants for bone and teeth restoration.[1] Nowadays, the advanced processing 
methods and new chemical strategies allow the incorporation of drugs within them or on their 
functionalized surfaces. In this regard, bioceramics can act as local drug delivery systems to treat 
bone defects, infections, tumours, and osteoporotic fra tures. The synergy of the bioactive 
behaviour of bioceramics together with their capability for local drug delivery is an outstanding 
perspective for bone therapy purposes.[2] 
Specific long-term situations could require the promotion or retardation of drug release, depending 
on the disease evolution. For this purpose, implantable systems that are able to respond to external 
stimuli magnetic fields or internal pH changes are t the forefront of research..[3] 
Between bioceramics there are melted silica-based bioactive glasses first prepared in 1969 by 
Hench et al.[4] From a biological and chemical point of view, they exhibit many of the properties 
associated with an ideal material for grafting and scaffolding. In the early 1990s bioactive glasses 
were prepared by the sol–gel process for the first t me.[5] Their bio-functionalization provides 
added value to the implant, since the graft not only fills and repairs the defect, but also acts as a 
drug delivery system, which can supply osteoregenerativ  agents locally.[6] 
The possible causes for a bone defect are numerous, but most of the studies involving bioceramic–
drug associations have addressed one of the following therapies: i) bone regeneration in critical 
defects, ii)  bone infection treatments, iii)  osteoporotic fracture consolidation and iv) bone tumour 
treatments.[2,7] 
Concerning tumour treatments, implantation of bioceramic bone grafts combined with specific local 
cancer treatments is an excellent alternative way to restore large bone defects that occur after 
tumour extirpation or partial bone resection resulting in tumour inhibition with low levels of 
systemic toxicity. Most current therapies for cancer tr atment based on systemic administration of 
conventional cytotoxic agents cause severe side effcts in the patient and are of limited 
effectiveness. Many studies[8-10] could be attributed to a lack of specificity of the antitumor drugs 
that have been developed so far, which cause collatera  damage to healthy cells. To resolve these 
problems, one of the strategies being investigated is to design specific drug delivery systems that 
can target and carry on effective dose of drug molecules to cancerous cells or tissues. The success 
of this strategy depends on the ability to design and synthesize a biocompatible nanocarrier suitable 
for transferring high drug loadings, avoiding premature release of it before reaching its 
destination.[11-14] 
Stimuli-responsive DDSs, also denoted smart DDSs, are designed to avoid the premature release of 
drug molecules before the target cell or tissue is r ached.[15] Changes in the pH of an environment 
is an attractive release trigger because some human tissues under pathological conditions (tumours, 
inflammation, etc.), as well as endosomal cell compartments, have a more acidic pH than human 
plasma and/or healthy tissues.[2,3,16] 
To this purpose, a bioactive glass with a covalent pH sensitive functionalization has been 
developed. Hydrazones and the amides of unsaturated anhydrides are among the most frequently 
used pH-sensitive spacers in drug delivery.[17] 
The method of surface modification of glasses is crucial for the subsequent applications as pH-
responsive nanodevices. α,β-Unsaturated dicarboxylic acid anhydrides were first reported as pH-
sensitive spacers by Shen and Ryser in 1981.[18] The amino group of daunorubicin was 
functionalized with maleic and cis-aconitic anhydrides, and the derivatives were conjugated to 
aminoethyl polyacrylamide beads through their carboxylic groups. The cis-aconityl linkage proved 
to be pH-sensitive, with a maximum release of 66% of bound daunorubicin after 6 h at pH 4. At pH 
7, the linker proved very stable, and no daunorubicin was detected even after 4 days. Cytotoxicity 
tests on WEHI-5 cells confirmed this result, showing up to 90% cell growth inhibition after 18 h at 
pH 5, compared to a total lack of inhibition at pH 7. The maleic anhydride derivative, on the other 
hand, showed no daunorubicin release nor cytotoxicity, even after incubation in acidic medium. The 
authors concluded that in the intermediate cis-aconityl daunorubicin, the γ carboxyl reacts with the 
amino groups on the carrier; during the release, th hydrolysis of the amide bond undergoes 
intramolecular catalysis by the β carboxyl; on the other hand, the maleyl derivative, lacking the free 
carboxyl function, doesn’t work. Following these results, a considerable amount of literature has 
flourished over the years; the studies are related to cis-aconitic anhydride as pH-sensitive spacer 
[19,20] for the drug delivery of doxorubicin, conjugated with polyamidoamines,[17,21,22] with 
chitosan[23,24] or modified polyethylene glycol.[25] 
Only very recently, Zhang et al.[26] used maleic anhydride to conjugate doxorubicin to a folate-
decorated pullulan. Pullulan was first functionalized with maleic anhydride, and then, after 
activation of the maleamic acid, doxorubicin was conjugated. Total amount of bound doxorubicin 
was determined by fluorescence spectrophotometry, and the conjugate was characterized by NMR 
spectroscopy. Release tests showed a release of 60% of total bound doxorubicin at pH 5.0 which is 
comparable with the results obtained with cis-aconitic anhydride. Cytotoxicity tests on human 
breast cancer cells confirmed the release results. Compared to Shen and Ryser's earlier work,[18] 
this study shed a new light on maleic anhydride as a pH-sensitive spacer, and inspired our work on 
the functionalization of bioactive glasses. 
In this preliminary study, 5-aminofluorescein (5-AF), a derivative of fluorescein containing a 
primary amino group, has been used as model molecule to simulate a drug. This dye is 
characterized by low cost and low toxicity, and thanks to its high molar absorptivity (77,000 L 
mol−1 cm−1)[27] it can easily be detected by means of absorption and emission spectroscopies 
(absorption at 494 nm and emission at 519 nm). It can be also used to monitor the localization of 
these biologically active molecules in living cells and provide a useful tool for linking biochemical 
investigation with optical visualization methods.[28-31] The combination of 5-AF and maleic 
anhydride with bioactive glasses has generated a large range of novel hybrid materials tailored to 
applications in localized drug delivery systems for b ne diseases. 
In the present paper a covalent glasses functionalization by means of two different routes has been 
carried out. Through these methods a pH-sensitive boactive glass was realized by covalently 
immobilizing 5-AF molecules onto the surface of the bioactive glass with maleic anhydride as 
linker molecule. Indeed, the efficiency of the functionalization has been verified by means of 
different physico-chemical characterization techniques. To verify the behaviour of the materials 
after the covalent functionalization/conjugation procedure, delivery tests in simulated body solution 
at different pH have been performed showing a pH-sensitive drug delivery behaviour. 
 
Materials 
3-Aminopropyltriethoxysilane (APTES) containing glass. In order to obtain the sol-gel amino-
propyl bioactive glass the conventional SiO2 source (tetraethyl orthosilicate, TEOS) was partially 
substituted with 3-aminopropyltriethoxysilane (APTES). Triethylphosphate (TEP) and calcium 
nitrate tetrahydrate (Ca(NO3)2·4H2O) have been used as P2O5 and CaO sources, respectively. The 
glass theoretical composition is 80% SiO2, 15% CaO and 5% P2O5 (%mol); the percentage of 
APTES used as precursor of SiO2 is 25 %mol. A water solution was prepared dissolving specific 
amounts 2.61 g of Ca(NO3)2·4H2O in a mixture of 0.2 ml HCl (37 wt% % w/w) and 5.0 ml of H2O. 
This aqueous solution was added to 40 ml of ethanol where 10.0 ml of TEOS and 3.5 ml of APTES 
were mixed; 1.3 ml of TEP had been previously added to each APTES/ EOS mixtures (each 
addition every 3 hours), in order to obtain the stoichi metric compositions. The solutions were then 
stirred for 1 hour and cast in Teflon® containers, that were hermetically closed and kept 1 day at 
room temperature for gelation. Gels were then aged 1 day at 333K. In order to remove the nitrates 
eventually still present in the sample the gel has been washed with a 0.1M Ca102  Ca(OH)2 solution 
for 1 hour under magnetic stirring. 
The aged systems were treated at 423K for 3 hours in an open Al2O3 crucible (heating ramp: 
2˚C/min); the latter temperature value has been chosen on the basis of the thermogravimetric 
analyses performed on the APTES containing samples. This is the highest calcinatio  emperature 
to be used in order to avoid the decomposition of the -CH2-CH2-CH2-NH2 chains of APTES 
molecules inserted during the synthesis. Finally the obtained powders were grounded in an agate 
mortar to Ø<500µm. This starting glass will be named APTES-SG. APTS25SG423. 
 
Methods 
Functionalization and Conjugation Reactions 
Functionalization of APTES-containing glass with maleic anhydride (APTES-SG-MA 
APTS25SG423MA). 0.50 g of APTS25SG423 APTES-SG glass (1.75 mmol NH2), 0.17 g of maleic 
anhydride (1.75 mmol) and 10 mL anhydrous diethyl ether were introduced in a round bottom flask, 
previously dried in oven and flushed with Ar. The suspension was let under stirring at room 
temperature for 5 min, then filtered on Buchner funnel and washed with acetone, yielding 0.22 g of 
APTES-SG-MA APTS25SG423MA. The amount of NH2 groups available at the glass surface after 
reaction, determined by acid-basic titration, was 0,9 mmol/g. This datum indicate that the degree of 
conjugation is ~75% (See Table 1). 
Conjugation of APTS25SG423MA PTES-SG-MA with 5-aminofluorescein (APTES-SG-MA–AF) 
APTS25SG423MA- F). 1.47 g of maleilated APTS25SG423 APTES-SG (3.82 mmol –COOH), 2.93 
g of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (15.3 mmol), 1.76 g N-
hydroxysuccinimide (15.3 mmol) and 110 ml anhydrous DMSO were introduced in a round bottom 
flask, previously dried in oven and flushed with Ar, and let under stirring for 30 min at r.t. in dark; 
5-aminofluorescein (1.33 g, 2.98 mmol) was then dissolved in 30 mL anh. DMSO and flushed with 
Ar; the orange solution was added dropwise to the glass suspension, and the mixture was let under 
stirring at r.t. in dark for 1 hour, then filtered on a Buchner funnel and washed with DMSO and 
acetone, giving 1.35 g of APTS25SG423MA-AF APTES-SG-MA–AF conjugate. The conjugation 
was confirmed by means of Raman spectroscopy and TGA analysis (See Results and Discussion 
Section). 
Conjugation of APTS25SG423 APTES-SG with N-(5-Fluoresceinyl)maleamic acid (APTES-SG-
MAAF APTS25SG423-MAAF). N-(5-Fluoresceinyl)maleamic acid (MAAF) was synthesized as 
described in literature.[32] 2.2 g of N-(5-fluoresceinyl)maleamic acid (4.93 mmol), 3.78 g of 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (19.7 mmol), 2.27 g N-
hydroxysuccinimide (19.7 mmol) and 140 ml anhydrous DMSO were introduced in a round bottom 
flask, previously dried in oven and flushed with Ar, and let under stirring for 3 hours at r.t. in dark, 
giving a dark yellow solution; 1.41 g of APTS25SG423 APTES-SG glass (4.93 mmol NH2) were 
then introduced and the mixture was reacted at r.t. in dark for 1 hour, then filtered on a Buchner 
funnel and washed with DMSO and acetone, giving 1.31 g of APTS25SG423-MAAF APTES-SG-
MAAF conjugate. The conjugation was confirmed by means of Raman spectroscopy and TGA 
analysis (See Results and Discussion Section). 
 
Characterization techniques 
Scanning electron microscopy (SEM). SEM microscopy was used to investigate any effect of the on 
the morphology of bioactive glasses after the functio alization/conjugation reactions. The images 
were obtained with a ZEISS ECO 50 XVP microscope equipped with a LaB6 source, with 
acquisition of images at 15 kV. For each sample, four different sample areas were investigated. 
Raman spectroscopy. FT-Raman spectra were collected directly on the glass powders in the 4000-
100 cm-1 range. A Bruker Vertex 70 instrument with the RAM II accessory, equipped with NdYAG 
laser (1064 nm) was used: 15000 scans with a mean laser power of 50 mW were accumulated for 
each sample. 
Acid-base titration. Acid-base titration was conducted by suspending the sample (50 mg) in 10 ml 
of HCl solution (0.1 M) for 1 hour. Then, the solution was centrifuged to remove glass powder and 
4 ml of the acid solution (after the glass contact) are titrated with NaOH solution (0.1 M) using 
phenolphthalein as indicator. Data were a mean of three independent determinations on different 
samples. 
Thermogravimetric analyses and differential thermal c orimetry (TGA-DSC). To determine the 
amount of organic functionalization, thermo gravimetric analyses coupled with differential thermal 
calorimetry are performed. A TA instrument Q600 SDT connected with a simultaneous DSC-TGA 
heat flow analyser has been used. 
All measurements are carried out under N2 flow (ramp: 10 °C·min
-1) in the 50-900 °C temperature 
range. 
 
pH-Dependent release tests 
In order to evaluate the bond stability at different pH values, 10 mg of conjugate systems were 
soaked in 2 ml of buffered solution at different times: 4 hours, 2 and 7 days. Two buffered solutions 
are used: i) buffer at pH = 4.2 (acetic/acetate buffer); ii  buffer at pH = 7.4 (PBS buffer). After 
different soaking times to remove the powder, the solutions were filtrated and analysed by 
fluorescence spectroscopy. 
Fluorescence spectroscopy. All measurements were performed using a JASCO FP6200 
fluorescence spectrophotometer. The slits were adjusted to achieve a spectral bandwidth of 2 nm, 
and the spectra were obtained with a 1-nm step size and 1-s integration time. The samples were 
excited at a wavelength of 490 nm. The standards of 5-AF were prepared in the concentration range 
between 10-5 - 10-7 M, because in this range the intensity of fluorescence band at 510 nm was 
proportional to the concentration (Abs in the range 0.1 - 0.2). As fluorescence properties of the 5-
AF was strictly pH-dependent, before the measurements the pH of both standard and samples 
solutions was adjusted to pH ~ 7.4 using phosphate buff red solution (PBS). 
Results and Discussion 
 
Two different synthetic routes were explored in the conjugation of 5-aminofluorescein to the 
APTES-containing glass. 
In the first approach, the glass was functionalized with maleic anhydride and then 5-AF was 
conjugated. (Synthesis details are reported in the Methods section) 
 
------------------------------------------------------------- 
Please, insert here Scheme 1 
--------------------------------------------------------------  
 
In the second approach, 5-AF was reacted to maleic nhydride to give the maleamic acid and then 
conjugated to the glass. (Synthesis details are report d in the Methods section). 
 
------------------------------------------------------------- 
Please, insert here Scheme 2 
--------------------------------------------------------------  
 
The second way of synthesis, frequently used in the drug delivery of doxorubicin,[17-23,33,35] 
particularly fits our system, since glass degradation proved a limiting factor on reaction times. In 
this synthetic approach, the bioglass has to endure only one reaction step, and is less subject to 
disgregation on solvents’ part. 
 
Samples Characterization  
In Figure 1 SEM micrographs of the samples before and after th functionalization/conjugation 
reactions are reported. 
 
------------------------------------------------------------- 
Please, insert here Figure 1 
------------------------------------------------------------- 
 
Concerning the starting glass (Section A) the size of the aggregates is in the 10-50 µm range and its 
shape is angular.[35] The morphology of the sample after the reaction with maleic anhydride is 
quite similar: it is possible to observe the presence of larger and homogeneously distributed 
aggregates with respect to the starting glass (probably the anhydride can favour the aggregation; 
Section B). 
In the case of samples conjugated with 5-AF the morph logy is modified; the glass aggregates 
become more regular also with a decreased size. These changes are probably ascribable to the 
magnetic stirring and to the solvent used in the conjugation reaction. The difference in the 
conjugation route (first and second route) does not affect the glass morphology. 
 
In Figure 2 Raman spectra carried out on the APTS25SG423 APTES-SG samples before and after 
the covalent functionalization with maleic anhydride and the conjugation with 5-AF are reported. 
 
------------------------------------------------------------- 
Please, insert here Figure 2 
--------------------------------------------------------------  
 
By the inspection of Raman spectra the following features can be evidenced: 
i) the bands at ~2960, ~2940 and ~2890 cm-1 typical of asymmetric and symmetric C-H stretching 
vibrations are clearly detectable in all samples; these bands are due to the presence of APTES 
anhydride and 5-AF molecules. The intensity ratio of these bands changed after the 
functionalization with the anhydride and 5-AF with respect to APTS25SG423 APTES-SG glass; 
ii)  the bands at ~1650 and ~1600 cm-1 are due to carbonyl groups stretching vibrations typical of 
carboxylic acid and amide, respectively. These bands appear on the glass after the covalent 
functionalization with the anhydride and 5-AF: the band at 1600 cm-1 is a clear indication of the 
formation of an amide bond between the –NH2 groups present on the glass surface and the carbonyl 
group of the anhydride or between the carbonyl group f the anhydride and –NH2 groups of 5-AF; 
the intensity of this band increased after the conjugation; this is an indication of the formation of the 
second amide bond. On the opposite, the band at ~ 1650 cm-1 typical of C=O stretching vibration of 
carboxylic groups resulting from the anhydrides’ ring opening decreased after the conjugation with 
5-AF, another indication of the successful conjugation reaction. 
iii)  in the 1450-1200 cm-1 spectral range there are the characteristic bands of C-H bending modes; 
iv) the sharp band at ~1040 cm-1 is typical ascribable of both carbonate and silicate species; it can 
be assigned to both ionic carbonate and to breathing motions of planar three-membered silica rings, 
νsym (Si-O) and νasym (Si-O) of the Si-O-Si groups, respectively; indeed, vibrational evidences for 
the presence of Si-O-H groups could also be present in this spectral region. All the mentioned 
vibrational features fall in the same range and it is not possible to isolate the single bands but the 
carbonate modes are more intense with respect to silica one. 
Raman spectra confirm the efficiency of the covalent fu ctionalization with both anhydride and 5-
AF with the formation of an amide bond between the anhydride with the amino groups of both glass 
and 5-AF. 
This is a very good result highlighting the ability of functional groups present on the material 
surface to be conjugated with molecules of biological interest. 
In Figure 3 Raman spectra carried out on the APTS25SG423 APTES-SG samples after the 
conjugation with N-(5-Fluoresceinyl)maleamic acid are reported. 
 
------------------------------------------------------------- 
Please, insert here Figure 3 
--------------------------------------------------------------  
 
Raman spectrum after glass functionalization with N-(5-Fluoresceinyl)maleamic acid presents the 
same features described previously confirming the formation of amide bonds. Comparing the 
spectra of the samples after the two different functio alization routes there are no significative 
differences. 
The amount of 5-AF conjugated with the two different routes are evaluated by means of 
thermogravimetry (TGA-DSC). Data are reported in Table 2.  
 
------------------------------------------------------------- 
Please, insert here Table 2 
--------------------------------------------------------------  
 
In order to evaluate the amount of organic molecules present in/on the glass the weight loss in the 
range between 343-673 K has been considered. Concerni g the starting glass APTS25SG423 
APTES-SG the % of weight loss is ~ 26 wt% ascribable to the presence of APTES molecules in the 
glass matrix. After the functionalization with maleic anhydride (APTS25SG423-MA  APTES-SG-
MA) the % of weight loss is ~ 27 wt%, this datum is closer to that of the starting glass s a 
consequence of the low molecular weight of maleic anhydride with respect to glass matrix. After 
the conjugation reactions with 5-AF the weight loss increased with respect to the starting glass. In 
the case of the first conjugation route (APTS25SG423MA-AF APTES-SG-MA-AF), starting from 
APTS25SG423MA APTES-SG-MA sample, the % of weight loss is % ~ 92 wt% whereas in the 
case of the second conjugation route (APTS25SG423-MAAF  APTES-SG-MAAF), starting from 
APTS25SG423 APTES-SG sample, the % of weight loss is ~ 71 wt%. From these data it is possible 
to conclude that the first method allows to conjugate the greatest amount of 5-AF (≈65 vs 44 wt%); 
this difference can be due to the fact that N-(5-Fluoresceinyl)maleamic acid possesses a greater 
steric hindrance with respect to maleic anhydride preventing the functionalization of vicinal –NH2 
glass surface functionalities. As a consequence of the high molecular weight of 5-AF there is an 
increment of weight losses. 
In order to evaluate the efficiency of the pH sensitive bond after the two conjugation reactions, 
release tests in buffered solutions at pH 7.4 and 4.2 were performed. 
The release data are reported in F gure 4 and in Table 3. The amount of 5-AF released has been 
determined by means of fluorescence spectroscopy. 
 
------------------------------------------------------------- 
Please, insert here Figure 4 
------------------------------------------------------------- 
 
The release of 5-AF presents exhibits a time-dependent trend: increasing the soaking times th  
amount of 5- AF released from both materials functionalization route is increased. This datum 
confirms the ability of these materials to act as controlled drug delivery system.  
Indeed, comparing the release at two different pH (see Table 3) it is possible to note that after one 
week, at pH 4.2 the amount of 5-AF released at pH 4.2 is higher than at pH 7.4 in both conjugation 
routes, . The amount of 5-AF released is higher at acid pH with respect to physiological one which 
is consistent with the development of a pH-sensitive drug delivery system.  
This evidence demonstrated that the amount of 5-AF released is higher at acid pH with respect to 
physiological one which is consistent with the development of a pH-sensitive drug delivery system 
 
------------------------------------------------------------- 
Please, insert here Table 3 
-------------------------------------------------------------- 
 
For short soaking times, however, in the first conjugation route the amount of 5-AF released at 
physiological pH is higher than of the second route. This result can be explained considering that, in 
addition to covalent grafting through APTES chains, the 5-AF can interact by means of weak 
interactions with silanols on the bioactive glasses urface mainly for the first functionalization route 
[36-38]. In order to remove the physisorbed 5-AF repeated rinsing with polar solvents (DMSO, 
acetone) were performed on bioactive glass after th functionalization, despite this physisorbed 5-
AF was not completely removed and due to its higher solubility in physiological buffer it is released 
in buffered solution at pH 7.4. 
Finally, comparing the amount of 5-AF released in the case of the two conjugation reactions, for the 
second conjugation route (less efficient with respect to the first one ascribable to less amount of 
both physisorbed and covalently bonded 5-AF) the percentage of 5-AF released after one week is 
lower with respect to the material conjugated with the first route. In the second route of 
functionalization the conjugate is more stable. This seems to confirm that the amount of 
physisorbed 5-AF plays a significant role in the first conjugation route. 
 
A pictorial representation of the functionalized bioactive glass and its behaviour in different 
buffered solutions is reported in Scheme 3.  
 
------------------------------------------------------------- 




Concerning the total amount of 5-AF released, the percentage of 5-AF released after 7 days is less 
than 2 1 wt%. The maximum release amount is 0.073 mg in 5 mL, corresponding to 14.6 mg/L. 
This datum is consistent with the very low solubility of 5-AF in aqueous medium (~11 mg/L at pH 
= 4).[39] It is worth to note that, the conditions used for the in-vitro release tests are very different 
from the ones in the biological environment where th re is a continuous flow of biological fluids. 
This feature was not reproduced in our in-vitro release tests where the buffered solution in contat 
with the systems did not change. 
Indeed, the half maximal inhibitory concentration (IC50) for doxorubicin, an anticancer drug 
commonly used for the treatment of osteosarcoma, is in the range between 0.33-1.1 mg/L.[40] Since 
the drug could be delivered directly in-situ in the tumour site, avoiding the first-pass metabolism, 
the therapeutic effects can be achieved even with the low amount released from our conjugated 
bioactive glass. Indeed, the release of a small amount of drug avoids the toxic effects typical of the 
conventional drug administration. 
In order to analyze the effects of glass dissolution in the two buffered solutions after 7 days of 
soaking, the samples have been analyzed by means of SEM. In Figure 5 the micrographs of the 
samples before and after 7 days of soaking in buffered solution at pH 7.4 are reported. For the sake 
of brevity, the micrographs of the samples soaked 7 days at more acid pH are not reported as no 




Please, insert here Figure 5 
--------------------------------------------------------------  
 
After 7 days soaking the glasses aggregates were cov red by an external layer made up of new 
particles whose morphology and composition (see EDS spectrum, section C of Figure 5) is 
ascribable to the formation of an apatite-like phase. 
 
Conclusions 
The keystone to building new, specific and smart therapies against cancer in the future consists in 
the exploitation of the intracellular or external changes. 
The development of bioceramics containing a stimuli-responsive covalent bond which can be 
hydrolyzed in acidic medium, is an ever-evolving research field for specific cancer therapies. 
The synergy of the bioactive behaviour of bioceramics together with their capability for local drug 
delivery is an outstanding perspective for bone therapy purposes. 
In the present paper we reported preliminary data for the development of a smart pH-responsive 
bioactive glass. 
Bioactive glass has been conjugated with 5-aminofluorescein (5-AF), mimetic for a amino-
containing anticancer drugs such as doxorubicin usig a pH-sensitive spacer (maleic anhydride). 
The physico-chemical characterization techniques confirm the glass conjugation. 
Release tests were performed at two different pH (4.2 and 7.4) showing a higher release at acid pH 
with respect to physiological one. This preliminary datum can be a useful tool in the development 
of a pH-sensitive drug delivery system. 
The percentage of 5-AF released after 7 days is less than 1 wt%. 2% Despite the low solubility of 5-
AF and considering the very low IC50 for doxorubicin, the therapeutic effects can be achieved even 
with the low amount released from our system where the drug would be delivered directly in the 
tumour site.  
These preliminary data are promising results in view of the development of a pH-sensitive drug 
delivery system. As future perspective, since aromatic amines are less basic and less nucleophilic 
than their alkyl counterparts due to the resonance eff ct, the aromatic amine of 5-AF will be 
derivatized in order to introduce an aliphatic one. Indeed, doxorubicin, an anticancer drug 
containing an amino group in the structure, will be used instead of 5-AF and a complete more 
detailed release kinetics will be performed. 
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Scheme 3. Representation of the different behaviours of the pH-responsive bioactive glass in 






































































































Figure 1. SEM micrographs (500X)of the APTES-glass before and after the conjugation reactions. 
Section A: as-synthesized glass (APTS25SG423 APTES-SG); Section B: APTS25SG423 APTES-
SG glass functionalized with maleic anhydride (APTES-SG-MA) ; Section C: APTS25SG423 





Figure 2. Raman spectra in the 3300-400 cm-1 spectral range carried out on: (a) as-synthetized 
samples (APTES-SG); (b) APTS25SG423 APTES-SG after functionalization with maleic 
anhydride (APTS25SG423MA APTES-SG-MA); (c) APTS25SG423MA APTES-SG-MA after 
functionalization with 5-aminofluorescein (APTES-SG-MA-AF) (c) are reported. As reference, the 
spectrum of pure 5-aminofluorescein (5-AF) is reported (see spectrum C). Blown-up in the 1700-
1500 cm-1 spectral range. 
 
 
Figure 3. Raman spectra in the 3300-400 cm-1 spectral range carried out on: (a) as-synthetized 
samples (APTES-SG); (b) APTS25SG423 APTES-SG after functionalization with N-(5-
Fluoresceinyl)maleamic acid (APTES-SG-MAAF). As reference, the spectrum of N-(5-
Fluoresceinyl)maleamic acid (MAAF) is reported (see spectrum D). Blown-up in the 1700-1500 
cm-1 spectral range. 
 
 
Figure 4. Section A: Release data reported as mg of 5-aminofluorescein (5-AF) released in 5 mL of 
solution at different times (4 hours, 2 and 7 days) at two different pH 4.5 for both conjugation 
routes. Section B: Release data reported as % of 5-aminofluorescein (5-AF) released at different 
times (4 hours, 2 and 7 days) at two different pH 4.5 for both conjugation routes. Section A: 
Phosphate buffer solution pH = 7.4; Section B Acetic/Acetate buffer solution pH = 4.2. Square 
symbols (): first conjugation route; Circle symbols (): second conjugation route; Solid symbols 
data reported as % of 5-AF released; open symbols data reported as mg of 5-AF released. 















































Figure 5. SEM micrographs of the sample APTES-25-SG-MA-AF as synthesized (Section A) and 







Table 1. Acid-base titration: amount of free –NH2 onto the glass surface before and after the 
functionalization/conjugation reactions. 
 
Samples Amount of free –NH2 
(mmol/g) 
% of glass –NH2 
functionalized 
APTS25SG423 APTES-SG 3.5 ± 0.1 / 
APTS25SG423 APTES-SG-MA 0.90 ± 0.1 74% 
 
Table 2. Percentage of weight loss in the temperature range between 373-673 K for the glass as-
synthesized and after each functionalization/conjugation reactions. Data are determined by means of 
TGA analysis. 
 
Samples % Weight loss ( wt%)  
(373-673 K) 
APTS25SG423 APTES-SG 26 ± 1% 
APTS25SG423 APTES-SG-MA 27 ± 1% 
APTS25SG423MA APTES-SG-MA-AF 92 ± 1% 
APTS25SG423 APTES-SG -MAAF 71 ± 1% 
 
 
Table 3. Amount of 5-AF released in solution at two different pH (7.4 PBS buffer and pH 4.2 
acetic/acetate buffer) after 4 hours, 2 and 7 days soaking time. Data are reported as i) mg of 5-AF 
released in 5mL of buffered solution (starting from 25 mg of samples soaked in 5 mL) or ii)  




16.25 mg (65%) of 5-AF in 25 mg of glass 
 
APTS25SG423 APTES-SG-MAAF 
11.20 mg (44%) of 5-AF in 25 mg of glass 
 Time 
mg of 5-AF released  
(% value) 
 Time 
mg of 5-AF released  
(% value) 
pH 7.4 4 h 0.013 ± 0.002 (0.08 %) pH 7.4 4 h *  
 2 d 0.016 ± 0.003 (0.10 %)  2 d *  
 7 d 0.019 ± 0.003 (0.12 %)  7 d 0.005 ± 0.001 (0. 4%) 
  
pH 4.2 4 h 0.050± 0.003 (0.31 %) pH 4.2 4 h 0.005 ± 0.001 (0.04%) 
 2 d 0.058 ± 0.007 (0.36 %)  2 d 0.008 ± 0.002 (0.07 %) 
 7 d 
0.073 ± 0.009 (0.44% 1.8 
%) 
 7 d 0.019± 0.003 (0.17 %) 
* under the lowest standard (corresponding to 0.005 mg released in 5 ml by 25 mg of sample) 
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